Intra-Cellular Therapies ... (ITCI)
Intra-Cellular Therapies Max Pain By Strike
ITCI trades at $131.87, 139.8% above the near-term max pain of $55 expiring Aug 15, 2025 (0 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($7-$90), reflecting growing call interest at higher strikes. High dispersion in max pain levels suggests competing forces and potential volatility.
Intra-Cellular Therapies Max Pain By Expiry
Max pain for ITCI shows an upward trend from 7 to 90, suggesting bullish positioning in longer-dated options. The 175% spread signals divergent expectations across timeframes. Most levels below 131.87 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 15, 2025 | 55 | -76.87 (-58.29%) |
| Nov 21, 2025 | 90 | -41.87 (-31.75%) |
| Dec 19, 2025 | 37.5 | -94.37 (-71.56%) |
| Jan 16, 2026 | 7 | -124.87 (-94.69%) |